Published in J Clin Microbiol on March 01, 2006
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (2001) 4.76
The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis (2001) 2.79
Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis (2001) 2.49
Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis (1999) 2.07
Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis (1997) 2.02
Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol (2000) 1.60
Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS (2000) 1.54
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis (2001) 1.53
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS (2003) 1.45
Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr (2001) 1.41
Human immunodeficiency virus type 1 RNA shedding in the female genital tract. J Infect Dis (1998) 1.35
Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group. J Clin Microbiol (2000) 1.31
Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis (2000) 1.23
Comparison of two amplification technologies for detection and quantitation of human immunodeficiency virus type 1 RNA in the female genital tract. Division of AIDS Treatment Research Initiative 009 Study Team. J Clin Microbiol (2000) 1.14
Genital tract and plasma human immunodeficiency virus viral load throughout the menstrual cycle in women who are infected with ovulatory human immunodeficiency virus. Am J Obstet Gynecol (2003) 0.99
Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ (2007) 1.91
Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada. AIDS (2007) 1.40
A national review of vertical HIV transmission. AIDS (2012) 1.38
The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can (2004) 1.38
Characterization of vaginal microflora of healthy, nonpregnant women by chaperonin-60 sequence-based methods. Am J Obstet Gynecol (2005) 1.28
Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice. CMAJ (2003) 1.25
Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis (2012) 1.16
Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay. J Clin Microbiol (2004) 1.15
Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens. J Clin Virol (2005) 1.13
Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Pediatr Infect Dis J (2003) 1.10
Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants. J Infect Dis (2008) 1.01
Genital tract and plasma human immunodeficiency virus viral load throughout the menstrual cycle in women who are infected with ovulatory human immunodeficiency virus. Am J Obstet Gynecol (2003) 0.99
A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy. Pediatrics (2006) 0.98
Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda. Int J Gynaecol Obstet (2013) 0.97
Association between short leukocyte telomere length and HIV infection in a cohort study: No evidence of a relationship with antiretroviral therapy. Clin Infect Dis (2014) 0.97
Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG (2003) 0.97
An association between cytomegalovirus infection and pre-eclampsia: a case-control study and data synthesis. Acta Obstet Gynecol Scand (2010) 0.94
Cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can (2010) 0.94
Community-based HIV and STI prevention in women working in indoor sex markets. Health Promot Pract (2012) 0.93
Identifying attitudes, beliefs and reported practices of nurses and doctors as immunization providers. J Adv Nurs (2010) 0.92
Canadian HIV Pregnancy Planning Guidelines: No. 278, June 2012. Int J Gynaecol Obstet (2012) 0.90
Leukocyte telomere length in HIV-infected and HIV-exposed uninfected children: shorter telomeres with uncontrolled HIV viremia. PLoS One (2012) 0.90
Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants. J Acquir Immune Defic Syndr (2012) 0.89
Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS). J Obstet Gynaecol Can (2009) 0.88
Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact. Pediatrics (2003) 0.88
Screening and management of bacterial vaginosis in pregnancy. J Obstet Gynaecol Can (2008) 0.88
Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda. BMJ Open (2014) 0.87
Immunization in pregnancy. J Obstet Gynaecol Can (2009) 0.86
Adult tetanus, diphtheria and pertussis immunization: knowledge, beliefs, behavior and anticipated uptake. Vaccine (2004) 0.85
Physician attitudes regarding pregnancy, fertility care, and assisted reproductive technologies for HIV-infected individuals and couples. HIV Clin Trials (2012) 0.84
Antibiotic therapy in preterm premature rupture of the membranes. J Obstet Gynaecol Can (2009) 0.83
Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programme. Antivir Ther (2003) 0.82
Principles of human teratology: drug, chemical, and infectious exposure. J Obstet Gynaecol Can (2007) 0.80
Chlamydia pneumoniae infection in preeclampsia. Hypertens Pregnancy (2010) 0.79
Needs, gaps and opportunities for infectious disease research in British Columbia: a perspective from population and public health. Can J Public Health (2007) 0.78
Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis. Hypertens Pregnancy (2010) 0.78
Psychometric assessment of the Multidimensional Quality of Life Questionnaire for Persons with HIV/AIDS (MQOL-HIV) in a sample of HIV-infected women. Qual Life Res (2004) 0.78
HIV screening in pregnancy. J Obstet Gynaecol Can (2006) 0.78
Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy. AIDS (2012) 0.78
Management of group B streptococcal bacteriuria in pregnancy. J Obstet Gynaecol Can (2012) 0.78
Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods. Can J Public Health (2011) 0.77
The prevalence of gestational diabetes mellitus and glucose abnormalities in pregnant women with hepatitis C virus infection in British Columbia. J Obstet Gynaecol Can (2010) 0.77
Immunization in pregnancy: No. 220, December 2008. Int J Gynaecol Obstet (2009) 0.77
Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy. J Obstet Gynaecol Can (2009) 0.75
[Cytomegalovirus infection in pregnancy]. J Obstet Gynaecol Can (2010) 0.75
Who knows more about immunization?: Survey of public health nurses and physicians. Can Fam Physician (2013) 0.75
Use of a violence risk assessment tool in an acute care hospital: effectiveness in identifying violent patients. AAOHN J (2006) 0.75
[Immunization in pregnancy]. J Obstet Gynaecol Can (2008) 0.75
J Obstet Gynaecol Can (2017) 0.75
Photodocumentation as an emergency department documentation tool in soft tissue infection: a randomized trial. CJEM (2013) 0.75
No. 211-Screening and Management of Bacterial Vaginosis in Pregnancy. J Obstet Gynaecol Can (2017) 0.75
Solicited adverse events after influenza immunization among infants, toddlers, and their household contacts. Pediatrics (2006) 0.75
One arm or two? Concurrent administration of meningococcal C conjugate and hepatitis B vaccines in pre-teens. Can J Public Health (2008) 0.75
Prolonged hungry bone syndrome in a 10-year-old child with parathyroid adenoma. Indian Pediatr (2009) 0.75
Immunization in pregnancy. J Obstet Gynaecol Can (2008) 0.75